Dengue Fever Dengue Normal Platelet Count



The platelets are plate shaped cells that are normally found circulating in the blood.

Dengue fever dengue normal platelet count. This fever causes the platelet and blood pressure to fall. Know the blood platelets count in dengue fever chikungunya malaria typhoid and platelet count normal range. However other biological effects have been attributed to platelets including angiogenesis extracellular matrix synthesis inflammation and immune response.

If severe dengue fever can damage the lungs liver or heart. Recovery generally takes two to seven days. Udit rohatgi explains some symptoms and prevention.

The most common symptoms include fever headache muscle and joint pains and skin rash. Dengue fever is a mosquito borne tropical disease caused by the dengue virus. Blood pressure can drop to dangerous levels causing shock and in some cases death.

Platelets were mainly associated with coagulation and hemostasis. Dengue is a deadly viral fever that is transmitted by the bite of aedes mosquito. A platelets count is a lab test that is conducted to measure the number of platelets present in the blood.

In the normal human body the platelet count in dengue ranges from 1 5 lacs to 4 lacs while platelet count in dengue decreases to as low as 20 000 to 40 000 you need to follow certain steps in increasing the platelet count in dengue fever patients. As platelet count comes down in dengue patients papaya leaf juice is a great remedy to increase platelet count. Symptoms typically begin three to fourteen days after infection.

Try these foods to recover from dengue. Dengue fever is endemic in most of the south east asian countries and carries its epidemic propositions during rainy season when mosquito breeding is high. Papaya leaf juice also improves immunity which also helps in treating dengue.

These may include a high fever headache vomiting muscle and joint pains and a characteristic skin rash. Dengue virus infection causes 200 million cases of severe flu like illness annually escalating to life threatening hemorrhagic fever or shock syndrome. One dengue fever vaccine dengvaxia is currently approved for use in those ages 9 to 45 who live in areas with a high incidence of dengue fever.